Manufacturing and Production

Showing 15 posts of 5813 posts found.

Arrowhead Collaboration presents Phase IIb data from Hepatitis B study

November 16, 2021 Manufacturing and Production

Arrowhead Pharmaceuticals Inc collaborator, Janssen Pharmaceuticals Inc, have presented clinical data from REEF-1, a Phase IIb study of different combination …

UK government to add Bharat Biotech’s Covaxin to list of approved travel vaccines

November 9, 2021 Manufacturing and Production

The UK government has stated that Covaxin is to be added to its list of approved COVID-19 vaccines for international …
dna

Harvard researchers target specific cells with gene therapy

November 9, 2021 Manufacturing and Production

A new technique to turn therapeutic genes on in specifically targeted cells has been developed, a potential game-changer in the …

Regeneron’s COVID antibody drug provides long term protection in clinical trial

November 9, 2021 Manufacturing and Production

Regeneron Pharmaceuticals have said that a single dose of its antibody COVID cocktail reduces the risk of contracting the virus …

BIAL appoints Joerg Holenz as R&D General Manager

November 8, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bial, appointments

BIAL have announced the appointment of Jorg Holenz as R&D General Manager, replacing Patricio da Silva, who steps down after …
kjm_cropped

HMNC Brain Health appoints Dr Katarina Jelic Maiboe Head of Regulatory Affairs

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HMNC Brain Health, appointments

HMNC Brain Health, a clinical-stage biopharma company pioneering the development of personalised therapies powered by predictive companion diagnostics, today announced …

Outsourcing in clinical trials: A response to rising challenges

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The pandemic has undoubtedly had a detrimental impact on the pharmaceutical and healthcare industries. Brexit has rubbed salt in the …

Risking it all after the pandemic: How companies can pick up the slack post-COVID-19

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pharmaceutical manufacturers have always been tasked with some of the most complex remits in the industry. Active pharmaceutical ingredients, potent …
beverley-carr-enhanced

Beverley Carr appointed Chief Business Officer for Amphista Therapeutics

November 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing amphista, appointments

Amphista Therapeutics have appointed Beverley Carr Chief Business Officer. Amphista is a leader in next generation targeted protein degradation (TPD) …

Mogrify appoint Tom Graney Non-Executive Director, Audit Chair and Capital Markets Advisor

November 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, mogrify

Mogrify Limited have announced the appointment of Tom Graney, CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor. He …

BioNet and BIA Separations collaborate on development of mRNA vaccines

November 2, 2021 Manufacturing and Production

BioNet, a leading biotech company manufacturing genetically engineered vaccines, and Sartorius’ company BIA Separations, have announced the development of an …

Transplant patients to have mandatory full COVID vaccinations at London Health Sciences Centre

November 2, 2021 Manufacturing and Production

The Ontario-based London Health Sciences Centre’s transplant program is implementing a full COVID-19 vaccination requirement for future organ transplant recipients …

Dunad Therapeutics and Novartis enter partnership to develop protein therapies

November 2, 2021 Manufacturing and Production

Biopharmaceutical company Dunad Therapeutics (Dunad) has annouced that it has entered into a strategic collaboration with Novartis, to develop orally …

FDA approve Novartis’ Scemblix to treat leukaemia

November 2, 2021 Manufacturing and Production

Novartis have announced that the FDA approved Scemblix® (asciminib) for the treatment of chronic myeloid leukaemia (CML) in two distinct …

NIHR funds COVID-19 antiviral trial

October 26, 2021 Manufacturing and Production

The National Institute for Health research has awarded funding to the University of Oxford, working with several other UK universities, …

Latest content